Treatment of TIGAR-overexpressing ESCC cell xenografts and patient-derived tumor xenografts in mice with a combination of glutaminase inhibitor and chemotherapeutic agents achieves significantly more efficacy than chemotherapy alone [30]. The gene discussed is GLS; the disease is esophageal squamous cell carcinoma.